SPDR S&P Biotech ETF (XBI) Stock Price, News, Quotes

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US ETFDetailed Quotes

XBI SPDR S&P Biotech ETF

Watchlist

88.250
-0.440-0.50%

Close Feb 26 16:00 ET

89.830High87.840Low

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Wall Street Today: Market Quaking With Anticipation, and Nvidia Delivers Beat
Kevin Travers16:57 ET
Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 20 Years
Benzinga15:00 ET
Earnings Call Summary | United Therapeutics(UTHR.US) Q4 2024 Earnings Conference
moomoo AI14:37 ET · Conference Call
Amgen Shares Snap Six Straight Sessions of Gains
Seeking Alpha14:16 ET
10 Health Care Stocks Whale Activity In Today's Session
Benzinga12:35 ET
Alnylam Pharmaceuticals Analyst Ratings
Benzinga11:34 ET · Ratings

Comments

Kim10

Jan 8 16:20

$SPDR S&P Biotech ETF (XBI.US)$ big bearish flow coming in looking like a hedge. Potential put play, small size.

topcing

Nov 4, 2024 21:29

$SPDR S&P Biotech ETF (XBI.US)$ yea

股勇者

Oct 25, 2024 10:17

$SPDR S&P Biotech ETF (XBI.US)$ 100 month end? ok?

Bellaah

Sep 11, 2024 11:10

$SPDR S&P Biotech ETF (XBI.US)$ 95

Moomoo Learn

Sep 6, 2024 03:05

Columns Navigating the wave of lower interest rates

Given the strong market expectations for a Federal Reserve rate cut, as indicated by the CME data with a 57% chance for a 25-basis-point reduction and a 43% chance for a 50-basis-point cut in September, investors are poised to reconsider their strategies.
With the Fed's September meeting likely to deliver a rate decrease, the question arises: how should investors allocate assets during an interest rate cut cycle? Let's delve into the tactics and consid...

CPI hits 3-year low: How will it sway the Fed rate decision?